These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3413127)

  • 1. Failure of a human immunodeficiency virus (HIV) immune globulin to protect chimpanzees against experimental challenge with HIV.
    Prince AM; Horowitz B; Baker L; Shulman RW; Ralph H; Valinsky J; Cundell A; Brotman B; Boehle W; Rey F
    Proc Natl Acad Sci U S A; 1988 Sep; 85(18):6944-8. PubMed ID: 3413127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
    Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
    J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.
    Arthur LO; Bess JW; Waters DJ; Pyle SW; Kelliher JC; Nara PL; Krohn K; Robey WG; Langlois AJ; Gallo RC
    J Virol; 1989 Dec; 63(12):5046-53. PubMed ID: 2555541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of HIV infection by passive immunization with HIV immunoglobulin.
    Prince AM; Reesink H; Pascual D; Horowitz B; Hewlett I; Murthy KK; Cobb KE; Eichberg JW
    AIDS Res Hum Retroviruses; 1991 Dec; 7(12):971-3. PubMed ID: 1812946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine.
    Arthur LO; Pyle SW; Nara PL; Bess JW; Gonda MA; Kelliher JC; Gilden RV; Robey WG; Bolognesi DP; Gallo RC
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8583-7. PubMed ID: 3479807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donors.
    Cummins LM; Weinhold KJ; Matthews TJ; Langlois AJ; Perno CF; Condie RM; Allain JP
    Blood; 1991 Mar; 77(5):1111-7. PubMed ID: 1995097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzees.
    Gibbs CJ; Peters R; Gravell M; Johnson BK; Jensen FC; Carlo DJ; Salk J
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3348-52. PubMed ID: 2014254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two different preparations of HIV immune globulin for efficiency of neutralization of HIV type 1 primary isolates.
    Nichols CN; Bernal I; Prince AM; Andrus L
    AIDS Res Hum Retroviruses; 2002 Jan; 18(1):49-56. PubMed ID: 11804556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees.
    Emini EA; Nara PL; Schleif WA; Lewis JA; Davide JP; Lee DR; Kessler J; Conley S; Matsushita S; Putney SD
    J Virol; 1990 Aug; 64(8):3674-8. PubMed ID: 2370678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-dependent enhancement of human immunodeficiency virus type 1 (HIV-1) infection in vitro by serum from HIV-1-infected and passively immunized chimpanzees.
    Robinson WE; Montefiori DC; Mitchell WM; Prince AM; Alter HJ; Dreesman GR; Eichberg JW
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4710-4. PubMed ID: 2471977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superinfection of a chimpanzee with a second strain of human immunodeficiency virus.
    Fultz PN; Srinivasan A; Greene CR; Butler D; Swenson RB; McClure HM
    J Virol; 1987 Dec; 61(12):4026-9. PubMed ID: 2446009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental vaccination against HIV-1 protects the chimpanzee against challenge with injections of infected lymphocytes].
    Girard M; Kieny MP; Barré-Sinoussi F; Nara P; Muchmore E; Fultz P
    Bull Acad Natl Med; 1992 Jun; 176(6):921-34; discussion 935. PubMed ID: 1464038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1.
    Scharf O; Golding H; King LR; Eller N; Frazier D; Golding B; Scott DE
    J Virol; 2001 Jul; 75(14):6558-65. PubMed ID: 11413323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenge of chimpanzees immunized with a recombinant canarypox-HIV-1 virus.
    Girard M; van der Ryst E; Barré-Sinoussi F; Nara P; Tartaglia J; Paoletti E; Blondeau C; Jennings M; Verrier F; Meignier B; Fultz PN
    Virology; 1997 May; 232(1):98-104. PubMed ID: 9185593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrathecal and intrathecal IgG response to the AIDS virus LAV/HTLV-III in experimental infection of chimpanzees.
    Goudsmit J; Gibbs CJ; Asher DM; Gajdusek DC
    Cancer Detect Prev Suppl; 1987; 1():509-14. PubMed ID: 3480064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
    Hu SL; Fultz PN; McClure HM; Eichberg JW; Thomas EK; Zarling J; Singhal MC; Kosowski SG; Swenson RB; Anderson DC
    Nature; 1987 Aug 20-26; 328(6132):721-3. PubMed ID: 3475581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120.
    Nara PL; Robey WG; Gonda MA; Carter SG; Fischinger PJ
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3797-801. PubMed ID: 3473484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nonprotective vaccination on antibody response to subsequent human immunodeficiency virus infection.
    Pincus SH; Messer KG; Hu SL
    J Clin Invest; 1994 Jan; 93(1):140-6. PubMed ID: 8282780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.